This track highlights how pharmaceutical companies can refine market sizing, leverage AI to unlock insights, and systematically integrate competitive intelligence into decision-making. It also questions whether technological progress in healthcare is truly translating into better patient outcomes, offering new perspectives on how to close the gap between innovation, access, and real-world value.